Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Erosion of dosage compensation impacts human iPSC disease modeling.

Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K.

Cell Stem Cell. 2012 May 4;10(5):595-609. doi: 10.1016/j.stem.2012.02.014.

2.

X chromosome inactivation and epigenetic responses to cellular reprogramming.

Lessing D, Anguera MC, Lee JT.

Annu Rev Genomics Hum Genet. 2013;14:85-110. doi: 10.1146/annurev-genom-091212-153530. Epub 2013 May 6. Review.

PMID:
23662665
3.

Regulation of X-chromosome inactivation by the X-inactivation centre.

Augui S, Nora EP, Heard E.

Nat Rev Genet. 2011 Jun;12(6):429-42. doi: 10.1038/nrg2987. Review.

PMID:
21587299
4.

Regulation of X-chromosome inactivation in development in mice and humans.

Goto T, Monk M.

Microbiol Mol Biol Rev. 1998 Jun;62(2):362-78. Review.

5.

Concise review: Pluripotency and the transcriptional inactivation of the female Mammalian X chromosome.

Minkovsky A, Patel S, Plath K.

Stem Cells. 2012 Jan;30(1):48-54. doi: 10.1002/stem.755. Review.

6.

Variable escape from X-chromosome inactivation: identifying factors that tip the scales towards expression.

Peeters SB, Cotton AM, Brown CJ.

Bioessays. 2014 Aug;36(8):746-56. doi: 10.1002/bies.201400032. Epub 2014 Jun 10. Review.

7.

Mechanisms of X-chromosome inactivation.

Chang SC, Tucker T, Thorogood NP, Brown CJ.

Front Biosci. 2006 Jan 1;11:852-66. Review.

PMID:
16146776
8.

Epigenetic alterations in human pluripotent stem cells: a tale of two cultures.

Wutz A.

Cell Stem Cell. 2012 Jul 6;11(1):9-15. doi: 10.1016/j.stem.2012.06.012. Review.

9.

X chromosome inactivation: how human are mice?

Vasques LR, Klöckner MN, Pereira LV.

Cytogenet Genome Res. 2002;99(1-4):30-5. Review.

PMID:
12900542
10.

Equality of the sexes: mammalian dosage compensation.

Brown CJ.

Semin Reprod Med. 2001 Jun;19(2):125-32. Review.

PMID:
11480909
11.

X chromosome dosage compensation: how mammals keep the balance.

Payer B, Lee JT.

Annu Rev Genet. 2008;42:733-72. doi: 10.1146/annurev.genet.42.110807.091711. Review.

PMID:
18729722
12.

A review of Rett syndrome (RTT) with induced pluripotent stem cells.

Balachandar V, Dhivya V, Gomathi M, Mohanadevi S, Venkatesh B, Geetha B.

Stem Cell Investig. 2016 Sep 28;3:52. eCollection 2016. Review.

13.

Imprinted X-chromosome inactivation: enlightenment from embryos in vivo.

Takagi N.

Semin Cell Dev Biol. 2003 Dec;14(6):319-29. Review.

PMID:
15015739
14.

Xist RNA and the mechanism of X chromosome inactivation.

Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B.

Annu Rev Genet. 2002;36:233-78. Epub 2002 Jun 11. Review.

PMID:
12429693
15.

The making of a Barr body: the mosaic of factors that eXIST on the mammalian inactive X chromosome.

Dixon-McDougall T, Brown C.

Biochem Cell Biol. 2016 Feb;94(1):56-70. doi: 10.1139/bcb-2015-0016. Epub 2015 Jun 24. Review.

PMID:
26283003
16.

Complexities of X chromosome inactivation status in female human induced pluripotent stem cells-a brief review and scientific update for autism research.

Dandulakis MG, Meganathan K, Kroll KL, Bonni A, Constantino JN.

J Neurodev Disord. 2016 Jun 9;8:22. doi: 10.1186/s11689-016-9155-8. eCollection 2016. Review.

17.

Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.

Brennand KJ, Landek-Salgado MA, Sawa A.

Biol Psychiatry. 2014 Jun 15;75(12):936-44. doi: 10.1016/j.biopsych.2013.10.025. Epub 2013 Nov 15. Review.

18.

X inactivation: pre- or post-fertilisation turn-off?

Ferguson-Smith AC.

Curr Biol. 2004 Apr 20;14(8):R323-5. Review. No abstract available.

Supplemental Content

Support Center